PHILADELPHIA, Penn. ( WJW) – Former President Joe Biden marked a significant milestone in his battle with prostate cancer. On ...

Researchers from UCLA have found a promising new way to help men with recurring prostate cancer live longer without their ...

Enzalutamide plus leuprolide reduces the risk of death by more than 40% in biochemically recurrent prostate cancer compared to leuprolide alone.

Kids with a rare bone cancer called Ewing sarcoma might live longer if prescribed pazopanib, a drug that blocks blood supply ...

Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate ...

WEDNESDAY, Oct. 22, 2025 (HealthDay News) — A powerful new drug combo has yielded a major breakthrough for men battling an ...

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...

Former President and Penn professor Joe Biden recently completed a round of radiation therapy to treat prostate cancer at ...

Cancer survivor Marc Hickel found relief from debilitating post-radiation complications through hyperbaric oxygen therapy at ...

Former President Joe Biden celebrated his completion of radiation therapy with family and doctors after being diagnosed with ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...